Adaptimmune Competitors and Similar CompaniesClear all
Adaptimmune's competitors and similar companies include PolyPid.
 Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. |  PolyPid PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API). | |
Founding Date | Founding Date 2008 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB | Locations Petah Tikva, IL HQ Summit, US |
Employees | Employees 4007% decrease | Employees 57 |
Valuation ($) | Valuation ($) 188.5 m | Valuation ($) 23.7 m |
Financial | ||
Revenue (est.) | Revenue (est.) $178m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods $70k (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit $178m (FY, 2024) | Gross profit N/A |
Net income | Net income ($70.8m) (FY, 2024) | Net income ($34.2m) (FY, 2025) |
Operating ⚠ | ||
Patent Applications | Patent Applications 69 (FY, 2016) | Patent Applications 49 (FY, 2017) |
Patents Issued | Patents Issued 173 (FY, 2016) | Patents Issued 104 (FY, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 107.5m | Total funding raised $ 103.8m |
For sources of this data, please see the company profile
View Company Profiles
PolyPid
HQ
Petah Tikva, IL
Employees
57
PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).
View company